• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconWegovy

Wegovy

Page 5 of 7
Dr. Patrick Carroll (right), Hims & Hers chief medical officer, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., Monday, May 20, 2024.
Conferences
Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By Marco Quiroz-GutierrezMay 20, 2024
woman shows off old oversized jeans
Health
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By Madison Muller, Jessica Nix and BloombergMay 20, 2024
Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders
Retail
Bernie Sanders urges Danish pharma giant Novo Nordisk to lower its drug prices: ‘Help the American people’
By Christian Wienberg and BloombergMay 13, 2024
woman measures her waist
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
Novo Nordisk CEO Lars Fruergaard Jorgensen Interview
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By Sanne Wass, Naomi Kresge and BloombergMay 1, 2024
Lars Fruergaard Jorgensen
Health
No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
By Jonel Aleccia and The Associated PressApril 12, 2024
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Health
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
By Naomi Kresge and BloombergApril 6, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
A person using Ozempic
Retail
Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations
By Ashleigh Furlong and BloombergMarch 13, 2024
tube of wegovy injections
Lifestyle
Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy 
By Prarthana PrakashMarch 8, 2024
62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’
Health
62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’
By Jonel Aleccia and The Associated PressMarch 7, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
Retail
Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
By Ryan HoggFebruary 8, 2024
Lars Fruergaard Jorgensen holding flashcards and talking
Retail
Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them
By Prarthana PrakashFebruary 5, 2024
1...
  • 3
  • 4
  • 5
  • 6
  • 7
7
Most Popular
Success
The heiress of $10 billion Perdue Farms and the $12 billion Sheraton Hotels empire wore hand-me-downs, still rides the subway, and flies economyplaceholder alt text
By Emma BurleighAugust 30, 2026
Success
31-year-old millionaire has zero sympathy for unemployed Gen Z's ‘excuses’—he says 'it is scarily easy' to build a business and get rich right nowplaceholder alt text
By Orianna Rosa RoyleAugust 31, 2026
Economy
We're living in the 'G-shaped economy'—where boomers control $90 trillion, and everyone else waitsplaceholder alt text
By Jason MaAugust 31, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.